↓ Skip to main content

The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic

Overview of attention for article published in Frontiers in immunology, March 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
14 X users

Citations

dimensions_citation
92 Dimensions

Readers on

mendeley
140 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic
Published in
Frontiers in immunology, March 2021
DOI 10.3389/fimmu.2021.637651
Pubmed ID
Authors

Priyanka Shah, Gabriela A. Canziani, Erik P. Carter, Irwin Chaiken

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 140 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 11%
Student > Ph. D. Student 14 10%
Student > Bachelor 13 9%
Student > Master 12 9%
Student > Doctoral Student 7 5%
Other 17 12%
Unknown 62 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 19 14%
Medicine and Dentistry 13 9%
Immunology and Microbiology 8 6%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Nursing and Health Professions 5 4%
Other 21 15%
Unknown 67 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 September 2023.
All research outputs
#4,937,785
of 25,773,273 outputs
Outputs from Frontiers in immunology
#5,490
of 32,357 outputs
Outputs of similar age
#118,815
of 455,691 outputs
Outputs of similar age from Frontiers in immunology
#290
of 1,341 outputs
Altmetric has tracked 25,773,273 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,357 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,691 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 1,341 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.